The Advisory Committee on Immunization Practices (ACIP) consists of medical and public health experts who develop recommendations on vaccine use in the United States. The ACIP meets 3 times per year, and members and Centers for Disease Control (CDC) staff present findings and discuss vaccine research, vaccine effectiveness (VE) and safety, clinical trial results, and labeling/package insert information. Outbreaks of vaccine-preventable diseases and vaccine shortages are also discussed. Nonvoting representatives from the American Academy of Pediatrics and the Pediatric Infectious Diseases Society are present. The ACIP met on June 22-23, 2016 to discuss proposed recommendations for influenza vaccination, for human papillomavirus (HPV) vaccine dosing schedules, for the cholera vaccine (CVD 103-HgR), and for the use of MenACWY in human immunodeficiency virus (HIV)-infected persons, as well as an overview of respiratory syncytial virus (RSV) vaccines, safety of maternal tetanus, diphtheria, acellular pertussis (Tdap) immunization, and laboratory containment of poliovirus type 2.
J Pediatric Infect Dis Soc
Adolescent; Advisory Committees; Centers for Disease Control and Prevention (U.S.); Child; Child, Preschool; Humans; Immunization Programs; Immunization Schedule; Infant; Infant, Newborn; Public Health Practice; Societies, Medical; United States; Vaccination
ACIP; CDC; immunization
Schuster, Jennifer E.; O'Leary, Sean; and Kimberlin, David W., "Update From the Advisory Committee on Immunization Practices." (2016). Manuscripts, Articles, Book Chapters and Other Papers. 1004.